دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
In the Literature
doi : 10.1093/cid/ciad275
Clinical Infectious Diseases, Volume 77, Issue 1, 1 July 2023, Pages i–ii
Risk Factors, Temporal Dependence, and Seasonality of Human Extended-Spectrum β-Lactamases-Producing Escherichia coli and Klebsiella pneumoniae Colonization in Malawi: A Longitudinal Model-Based Approach
Melodie Sammarro, Barry Rowlingson, Derek Cocker, Kondwani Chidziwisano, Shevin T Jacob, Henry Kajumbula, Lawrence Mugisha, David Musoke, Rebecca Lester, Tracy Morse, Nicholas Feasey, Chris Jewell
doi : 10.1093/cid/ciad117
Clinical Infectious Diseases, Volume 77, Issue 1, 1 July 2023, Pages 1–8
Sub-Saharan Africa has the highest estimated death rate attributable to antimicrobial resistance, especially from extended-spectrum β-lactamase-producing Enterobacterales (ESBL-E). However, the dynamics of human colonization in the community with ESBL-E are not well described.
Positive Impact of [18F]FDG-PET/CT on Mortality in Patients With Staphylococcus aureus Bacteremia Explained by Immortal Time Bias
Thomas W van der Vaart, Jan M Prins, Cornelis H van Werkhoven, Thijs ten Doesschate, Robin Soetekouw, Gitte van Twillert, Jan Veenstra, Bjorn L Herpers, Wouter Rozemeijer, Rogier R Jansen, Marc J M Bonten, Jan T M van der Meer
doi : 10.1093/cid/ciad112
Clinical Infectious Diseases, Volume 77, Issue 1, 1 July 2023, Pages 9–15
Several studies have suggested that in patients with Staphylococcus aureus bacteremia (SAB) [18F] fluorodeoxyglucose positron emission tomography/computed tomography ([18F]FDG-PET/CT) improves outcome. However, these studies often ignored possible immortal time bias.
Positron Emission Tomography in Staphylococcus aureus Bacteremia: Peeking Under the Covers
Todd C Lee, Emily G McDonald, Steven Y C Tong
doi : 10.1093/cid/ciad113
Clinical Infectious Diseases, Volume 77, Issue 1, 1 July 2023, Pages 16–18
The Who, What, When, and Where of Inpatient Direct Oral Penicillin Challenge—Implications for Health Services Implementation
Jason Anthony Trubiano, Sara Vogrin, Elise Mitri, Rebecca Hall, Ana Copaescu, Jamie Waldron, Joseph De Luca, Morgan Rose, Geoff Mackay, Belinda Lambros, Abby P Douglas, Natasha E Holmes, Kyra Y L Chua
doi : 10.1093/cid/ciad156
Clinical Infectious Diseases, Volume 77, Issue 1, 1 July 2023, Pages 19–22
Inpatient direct oral challenge programs are increasingly deployed as part of antimicrobial stewardship initiatives to reduce the burden and impacts of penicillin allergy labels on antibiotic prescribing. Using data from a prospective, multicenter cohort inpatient penicillin allergy program, we identify the key targets for delabeling to aid health service implementation.
Implementing Delabeling of Beta-Lactam Allergies: Getting to the “Why�?
Bruce M Jones, Christopher M Bland
doi : 10.1093/cid/ciad152
Clinical Infectious Diseases, Volume 77, Issue 1, 1 July 2023, Pages 23–24
The Coronavirus Disease 2019 Rebound Study: A Prospective Cohort Study to Evaluate Viral and Symptom Rebound Differences in Participants Treated With Nirmatrelvir Plus Ritonavir Versus Untreated Controls
Jay A Pandit, Jennifer M Radin, Danielle C Chiang, Emily G Spencer, Jeff B Pawelek, Mira Diwan, Leila Roumani, Michael J Mina
doi : 10.1093/cid/ciad102
Clinical Infectious Diseases, Volume 77, Issue 1, 1 July 2023, Pages 25–31
The uptake of nirmatrelvir plus ritonavir (NPR) in patients with coronavirus disease 2019 (COVID-19) has been limited by concerns around the rebound phenomenon despite the scarcity of evidence around its epidemiology. The purpose of this study was to prospectively compare the epidemiology of rebound in NPR-treated and untreated participants with acute COVID-19 infection.
Your Outpatient has Coronavirus Disease 2019: What Are the Treatment Options in the Current Severe Acute Respiratory Syndrome Coronavirus 2 Variant Climate?
William A Werbel, Ethel D Weld, Sonali D Advani, Payal K Patel, Maria E Sundaram, Varun K Phadke
doi : 10.1093/cid/ciad178
Clinical Infectious Diseases, Volume 77, Issue 1, 1 July 2023, Pages 32–37
Mutations accumulated by novel Severe Acute Respiratory Syndrome Coronavirus 2 Omicron sublineages contribute to evasion of previously effective monoclonal antibodies for treatment or prevention of Coronavirus Disease 2019 (COVID-19).
Clinical Impact of Polymerase Chain Reaction–Based Aspergillus and Azole Resistance Detection in Invasive Aspergillosis: A Prospective Multicenter Study
Sammy Huygens, Albert Dunbar, Jochem B Buil, Corné H W Klaassen, Paul E Verweij, Karin van Dijk, Nick de Jonge, Jeroen J W M Janssen, Walter J F M van der Velden, Bart J Biemond, Aldert Bart, Anke H W Bruns, Pieter-Jan A Haas, Astrid M P Demandt, Guy Oudhuis, Peter von dem Borne, Martha T van der Beek, Saskia K Klein, Peggy Godschalk, Lambert F R Span, Douwe F Postma, Greetje A Kampinga, Johan Maertens, Katrien Lagrou, Toine Mercier, Ine Moors, Jerina Boelens, Dominik Selleslag, Marijke Reynders, Willemien Zandijk, Jeanette K Doorduijn, Jan J Cornelissen, Alexander F A D Schauwvlieghe, Bart J A Rijnders
doi : 10.1093/cid/ciad141
Clinical Infectious Diseases, Volume 77, Issue 1, 1 July 2023, Pages 38–45,
Invasive aspergillosis (IA) by a triazole-resistant Aspergillus fumigatus is associated with high mortality. Real-time resistance detection will result in earlier initiation of appropriate therapy.
Hepatitis C Virus Reinfection in a Real-World Cohort of Homeless-Experienced Individuals in Boston
Marguerite E Beiser, Leah C Shaw, Savanna K Shores, Joanne M Carson, Behzad Hajarizadeh
doi : 10.1093/cid/ciad127
Clinical Infectious Diseases, Volume 77, Issue 1, 1 July 2023, Pages 46–55
People experiencing homelessness are disproportionately affected by hepatitis C virus (HCV) infection compared with housed populations. Surveillance for HCV reinfection after successful treatment is a critical step in the care cascade, but limited data on reinfection are available among this highly marginalized group.
Influenza Vaccination Uptake and Associated Factors Among Adults With and Without Human Immunodeficiency Virus in a Large, Integrated Healthcare System
Brandon M Imp, Tory Levine, Derek D Satre, Jacek Skarbinski, Mitchell N Luu, Stacy A Sterling, Michael J Silverberg
doi : 10.1093/cid/ciad106
Clinical Infectious Diseases, Volume 77, Issue 1, 1 July 2023, Pages 56–63
Influenza vaccination is recommended for adults regardless of human immunodeficiency virus (HIV) status. There may be facilitators or barriers to vaccinating people with HIV (PWH) that differ from people without HIV (PWoH). We sought to describe the uptake of influenza vaccination by HIV status and identify factors associated with vaccination.
Early Antiretroviral Therapy Not Associated With Higher Cryptococcal Meningitis Mortality in People With Human Immunodeficiency Virus in High-Income Countries: An International Collaborative Cohort Study
Suzanne M Ingle, Jose M Miro, Margaret T May, Lauren E Cain, Christine Schwimmer, Robert Zangerle, Helen Sambatakou, Charles Cazanave, Peter Reiss, Vanessa Brandes, Heiner C Bucher, Caroline Sabin, Francesc Vidal, Niels Obel, Amanda Mocroft, Linda Wittkop, Antonella d'Arminio Monforte, Carlo Torti, Cristina Mussini, Hansjakob Furrer, Deborah Konopnicki, Ramon Teira, Michael S Saag, Heidi M Crane, Richard D Moore, Jeffrey M Jacobson, W Chris Mathews, Elvin Geng, Joseph J Eron, Keri N Althoff, Abigail Kroch, Raynell Lang, M John Gill, Jonathan A C Sterne
doi : 10.1093/cid/ciad122
Clinical Infectious Diseases, Volume 77, Issue 1, 1 July 2023, Pages 64–73
Randomized controlled trials (RCTs) from low- and middle-income settings suggested that early initiation of antiretroviral therapy (ART) leads to higher mortality rates among people with HIV (PWH) who present with cryptococcal meningitis (CM). There is limited information about the impact of ART timing on mortality rates in similar people in high-income settings.
Timing of Antiretroviral Therapy in Cryptococcal Meningitis: What We Can (and Cannot) Learn From Observational Data
David R Boulware, Joseph N Jarvis
doi : 10.1093/cid/ciad123
Clinical Infectious Diseases, Volume 77, Issue 1, 1 July 2023, Pages 74–76
Natural History of Clostridioides difficile Colonization and Infection Following New Acquisition of Carriage in Healthcare Settings: A Prospective Cohort Study
Scott R Curry, Michelle T Hecker, Justin O’Hagan, Preeta K Kutty, Heba Alhmidi, Yilen K Ng-Wong, Jennifer L Cadnum, Annette L Jencson, Melany Gonzalez-Orta, Carlos Saldana, Brigid M Wilson, Curtis J Donskey
doi : 10.1093/cid/ciad142
Clinical Infectious Diseases, Volume 77, Issue 1, 1 July 2023, Pages 77–83
Limited information is available on the natural history of Clostridioides difficile colonization and infection in patients with new acquisition of C. difficile in healthcare settings.
Factors Associated With Discontinuation of Tuberculosis Preventive Treatment: Post Hoc Analysis of 2 Randomized, Controlled Trials
Alex Allard-Gray, Isaac Boakye, Alioune Camara, Lisa Eisenbeis, Eleny Guimarães-Teixeira, Oumou Sow, David Zielinski, Jonathon R Campbell, Dick Menzies
doi : 10.1093/cid/ciad164
Clinical Infectious Diseases, Volume 77, Issue 1, 1 July 2023, Pages 84–93
Adherence to tuberculosis preventive treatment (TPT) is an important determinant of clinical benefit. We assessed the association of participant behaviors early in TPT with subsequent discontinuation.
Impact of Community-Wide Tuberculosis Active Case Finding and Human Immunodeficiency Virus Testing on Tuberculosis Trends in Malawi
Rachael M Burke, Marriott Nliwasa, Peter J Dodd, Helena R A Feasey, McEwen Khundi, Augustine Choko, Rebecca Nzawa-Soko, James Mpunga, Emily L Webb, Katherine Fielding, Peter MacPherson, Elizabeth L Corbett
doi : 10.1093/cid/ciad238
Clinical Infectious Diseases, Volume 77, Issue 1, 1 July 2023, Pages 94–100
Tuberculosis case-finding interventions are critical to meeting World Health Organization End TB strategy goals. We investigated the impact of community-wide tuberculosis active case finding (ACF) alongside scale-up of human immunodeficiency virus (HIV) testing and care on trends in adult tuberculosis case notification rates (CNRs) in Blantyre, Malawi.
Finding Tuberculosis: More Evidence for Community-Wide Systematic Screening
Lelia H Chaisson
doi : 10.1093/cid/ciad232
Clinical Infectious Diseases, Volume 77, Issue 1, 1 July 2023, Pages 101–102
Yield and Efficiency of a Population-Based Mass Tuberculosis Screening Intervention Among Persons With Diabetes in Jiangsu Province, China
Qiao Liu, Nannan You, Juan Wen, Jianming Wang, Yang Ge, Ye Shen, Xiaoyan Ding, Peng Lu, Cheng Chen, Baoli Zhu, Limei Zhu, Wei Lu, Leonardo Martinez
doi : 10.1093/cid/ciad118
Clinical Infectious Diseases, Volume 77, Issue 1, 1 July 2023, Pages 103–111
The evidence-base for mass tuberculosis screening among persons with diabetes (PWD) is poor. We evaluated the yield and costs of mass screening among PWD in eastern China.
High Performance of Systematic Combined Urine Liboarabinomannan Test and Sputum Xpert MTB/RIF for Tuberculosis Screening in Severely Immunosuppressed Ambulatory Adults With Human Immunodeficiency Virus
Maryline Bonnet, Delphine Gabillard, Serge Domoua, Conrad Muzoora, Eugène Messou, Samreth Sovannarith, Duc Bang Nguyen, Anani Badje, Sylvain Juchet, Dim Bunnet, Laurence Borand, Naome Natukunda, Thị Hong Tran, Xavier Anglaret, Didier Laureillard, François-Xavier Blanc, for the Systematic empirical vs. Test-guided Anti-tuberculosis Treatment Impact in Severely immunosuppressed HIV-infected adults initiating antiretroviral therapy with CD4 cell counts <100/mm3 (STATIS) Agence Nationale de Recherche sur le Sida et les hépatites virales (ANRS) 12290 Trial Team
doi : 10.1093/cid/ciad125
Clinical Infectious Diseases, Volume 77, Issue 1, 1 July 2023, Pages 112–119
In people with human immunodeficiency virus (PWH), the World Health Organization–recommended tuberculosis (TB) 4-symptom screen (W4SS) targeting those who need molecular rapid testing may be suboptimal.
Impact of Treatment on Long-Term Survival of Patients With Mycobacterium avium Complex Pulmonary Disease
Joong-Yub Kim, Yunhee Choi, JiWon Park, Jin Mo Goo, Taek Soo Kim, Moon-Woo Seong, Nakwon Kwak, Jae-Joon Yim
doi : 10.1093/cid/ciad108
Clinical Infectious Diseases, Volume 77, Issue 1, 1 July 2023, Pages 120–126
Whether antimicrobial treatment improves long-term survival in patients with Mycobacterium avium complex pulmonary disease (MAC-PD) is unclear.
Effectiveness of Intermittent Screening and Treatment of Malaria in Pregnancy on Maternal and Birth Outcomes in Selected Districts in Rwanda: A Cluster Randomized Controlled Trial
Aline Uwimana, Reena Sethi, Monique Murindahabi, Celestin Ntirandeka, Emily Piercefield, Noella Umulisa, Andrew Abram, Erin Eckert, Kaendi Munguti, David Sullivan, Didier Uyizeye, Aimable Mbituyumuremyi, Julie R Gutman
doi : 10.1093/cid/ciad128
Clinical Infectious Diseases, Volume 77, Issue 1, 1 July 2023, Pages 127–134
Malaria during pregnancy can cause serious consequences including maternal anemia and low birthweight (LBW). Routine antenatal care (ANC) in Rwanda includes malaria symptom screening at each ANC visit.
A Case of Mpox Reinfection
Stefano Musumeci, Iris Najjar, Emmanuelle Boffi El Amari, Manuel Schibler, Frédérique Jacquerioz, Sabine Yerly, Adriana Renzoni, Alexandra Calmy, Laurent Kaiser
doi : 10.1093/cid/ciad147
Clinical Infectious Diseases, Volume 77, Issue 1, 1 July 2023, Pages 135–137
A healthy young man first diagnosed with mpox in May 2022 presented again in November 2022 with anal proctitis and a positive polymerase chain reaction on a rectal swab for Monkeypox virus after a recent trip to Brazil, where he engaged in condomless sexual intercourse with multiple male partners.
Programmatic Effectiveness of a Pediatric Typhoid Conjugate Vaccine Campaign in Navi Mumbai, India
Seth A Hoffman, Christopher LeBoa, Kashmira Date, Pradeep Haldar, Pauline Harvey, Rahul Shimpi, Qian An, Chenhua Zhang, Niniya Jayaprasad, Lily Horng, Kirsten Fagerli, Priyanka Borhade, Savita Daruwalla, Dhanya Dharmapalan, Jeetendra Gavhane, Shrikrishna Joshi, Rajesh Rai, Varsha Rathod, Keertana Shetty, Divyalatha S Warrier, Shalini Yadav, Debjit Chakraborty, Sunil Bahl, Arun Katkar, Abhishek Kunwar, Vijay Yewale, Jason R Andrews, Pankaj Bhatnagar, Shanta Dutta, Stephen P Luby
doi : 10.1093/cid/ciad132
Clinical Infectious Diseases, Volume 77, Issue 1, 1 July 2023, Pages 138–144
The World Health Organization recommends vaccines for prevention and control of typhoid fever, especially where antimicrobial-resistant typhoid circulates. In 2018, the Navi Mumbai Municipal Corporation (NMMC) implemented a typhoid conjugate vaccine (TCV) campaign. The campaign targeted all children aged 9 months through 14 years within NMMC boundaries (approximately 320 000 children) over 2 vaccination phases.
Gateway to Typhoid Conjugate Vaccine Introduction in India and Beyond—Programmatic Effectiveness of a Public Sector Typhoid Conjugate Vaccine Campaign in Navi Mumbai
Megan E Carey
doi : 10.1093/cid/ciad134
Clinical Infectious Diseases, Volume 77, Issue 1, 1 July 2023, Pages 145–147
An Unusual and Difficult to Detect Cause of Infection in Two Trauma Patients
Kim Yeoh, Dilare Aikeremu, Benjamin Aw-Yeong, Monica A Slavin, Eloise Williams
doi : 10.1093/cid/ciac748
Clinical Infectious Diseases, Volume 77, Issue 1, 1 July 2023, Pages 154–157
Cerebrospinal Fluid and Tuberculous Meningitis
Caryn M Upton, Lubbe Wiesner, Kelly E Dooley, Gary Maartens
doi : 10.1093/cid/ciad186
Clinical Infectious Diseases, Volume 77, Issue 1, 1 July 2023, Page 158
Reply to Upton et al
Russell R Kempker, Maia Kipiani, Charles A Peloquin
doi : 10.1093/cid/ciad188
Clinical Infectious Diseases, Volume 77, Issue 1, 1 July 2023, Pages 158–159
Applying Desirability of Outcome Ranking End Points
Michael W Dunne, Steven I Aronin, Anita F Das, Jayanti Gupta, Karthik Akinapelli, Michael T Zelasky, Sailaja Puttagunta, Helen W Boucher
doi : 10.1093/cid/ciad166
Clinical Infectious Diseases, Volume 77, Issue 1, 1 July 2023, Pages 159–161
Invasive Listeriosis in Southern Switzerland: A Local Problem That Is Actually Global
Marco Bongiovanni, Beatrice Barda, Gladys Martinetti Lucchini, Valeria Gaia, Giorgio Merlani, Enos Bernasconi
doi : 10.1093/cid/ciad193
Clinical Infectious Diseases, Volume 77, Issue 1, 1 July 2023, Pages 161–162
Cefepime for Ceftriaxone-Resistant Enterobacterales With Chromosomal AmpC β-Lactamases
Matthew W Davis, Abriana C Holzworth, Caleb E Rux, Dayna McManus, Jeffrey E Topal
doi : 10.1093/cid/ciad173
Clinical Infectious Diseases, Volume 77, Issue 1, 1 July 2023, Pages 162–163
Reply to Davis et al
Pranita D Tamma, Amy J Mathers, Eric Wenzler
doi : 10.1093/cid/ciad170
Clinical Infectious Diseases, Volume 77, Issue 1, 1 July 2023, Pages 163–165
Correction to: Association of Upper Respiratory Streptococcus pneumoniae Colonization With Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Adults
doi : 10.1093/cid/ciad191
Clinical Infectious Diseases, Volume 77, Issue 1, 1 July 2023, Page 166
